Quest Diagnostics announced that Sam Samad, their Executive Vice President and CFO, will participate in a fireside chat at the Jefferies Global Healthcare Conference in London on November 17, 2026. The session will be webcast live and available on the company's investor relations website, with an archived version accessible until December 1, 2026. This event offers investors insight into the company's financial outlook and strategic direction in healthcare diagnostics.
As of Nov 10, 2026 00:51 WIB, Quest Diagnostics (DGX) is trading at USD 258.45 on Pluang, showing a 1.10% increase in the last day. The company holds a market capitalization of $28.21 billion and offers a dividend yield of 1.35%. This price movement and dividend yield provide context for investors ahead of the upcoming Jefferies Global Healthcare Conference session featuring Quest's CFO.
